CVS re­sumes cov­er­age of block­buster blood thin­ner af­ter price drop fol­lows Jan­u­ary ex­clu­sion

Fol­low­ing some back­lash from the Amer­i­can Col­lege of Car­di­ol­o­gy and pa­tients, Bris­tol My­ers Squibb and Pfiz­er low­ered the price of their block­buster blood thin­ner Eliquis …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER